<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>2.494e-04</TD><TD>-8.30</TD><TD>NLRP14 (NLR family, pyrin domain containing 14)</TD><TD>protein interactions</TD><TD>338323</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.909e-04</TD><TD>-8.14</TD><TD>GEORGANTAS_HSC_MARKERS</TD><TD>MSigDB lists</TD><TD>GEORGANTAS_HSC_MARKERS</TD><TD>67</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,MECOM</TD></TR>
<TR><TD>3.646e-04</TD><TD>-7.92</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</TD><TD>75</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.827e-04</TD><TD>-7.87</TD><TD>SUN3</TD><TD>interpro domains</TD><TD>IPR030274</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>3.827e-04</TD><TD>-7.87</TD><TD>MDS1</TD><TD>interpro domains</TD><TD>IPR026710</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.827e-04</TD><TD>-7.87</TD><TD>Caspr2</TD><TD>interpro domains</TD><TD>IPR029831</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.252e-04</TD><TD>-7.76</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</TD><TD>81</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,MECOM</TD></TR>
<TR><TD>7.298e-04</TD><TD>-7.22</TD><TD>superior temporal gyrus development</TD><TD>biological process</TD><TD>GO:0071109</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>7.652e-04</TD><TD>-7.18</TD><TD>FAM198</TD><TD>interpro domains</TD><TD>IPR029207</TD><TD>2</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>7.652e-04</TD><TD>-7.18</TD><TD>Evi1/Prdm16</TD><TD>interpro domains</TD><TD>IPR030413</TD><TD>2</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.418e-04</TD><TD>-7.08</TD><TD>FAM198</TD><TD>pfam domains</TD><TD>PF15051</TD><TD>2</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>9.975e-04</TD><TD>-6.91</TD><TD>ZNF461 (zinc finger protein 461)</TD><TD>protein interactions</TD><TD>92283</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>TOX2</TD></TR>
<TR><TD>1.091e-03</TD><TD>-6.82</TD><TD>procollagen-lysine 5-dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0008475</TD><TD>3</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.094e-03</TD><TD>-6.82</TD><TD>clustering of voltage-gated potassium channels</TD><TD>biological process</TD><TD>GO:0045163</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.148e-03</TD><TD>-6.77</TD><TD>Procol_lys_dOase</TD><TD>interpro domains</TD><TD>IPR001006</TD><TD>3</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.186e-03</TD><TD>-6.74</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>6791</TD><TD>7</TD><TD>17775</TD><TD>7</TD>
<TD>SUN3,ZNF432,CNTNAP2,FAM198B,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>1.247e-03</TD><TD>-6.69</TD><TD>Fam107b (family with sequence similarity 107, member B)</TD><TD>protein interactions</TD><TD>66540</TD><TD>5</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.455e-03</TD><TD>-6.53</TD><TD>peptidyl-lysine 5-dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0070815</TD><TD>4</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.459e-03</TD><TD>-6.53</TD><TD>protein localization to juxtaparanode region of axon</TD><TD>biological process</TD><TD>GO:0071205</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.516e-03</TD><TD>-6.49</TD><TD>LYS_HYDROXYLASE</TD><TD>prosite domains</TD><TD>PS01325</TD><TD>3</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.564e-03</TD><TD>-6.46</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>156</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>1.683e-03</TD><TD>-6.39</TD><TD>2OG-FeII_Oxy</TD><TD>pfam domains</TD><TD>PF03171</TD><TD>4</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.824e-03</TD><TD>-6.31</TD><TD>vocal learning</TD><TD>biological process</TD><TD>GO:0042297</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.824e-03</TD><TD>-6.31</TD><TD>learned vocalization behavior or vocal learning</TD><TD>biological process</TD><TD>GO:0098598</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.824e-03</TD><TD>-6.31</TD><TD>imitative learning</TD><TD>biological process</TD><TD>GO:0098596</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.941e-03</TD><TD>-6.24</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_UP</TD><TD>MSigDB lists</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_UP</TD><TD>174</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>ZNF432,CNTNAP2</TD></TR>
<TR><TD>2.030e-03</TD><TD>-6.20</TD><TD>ATF2_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>ATF2_UP.V1_DN</TD><TD>178</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>ZNF432,FAM198B</TD></TR>
<TR><TD>2.098e-03</TD><TD>-6.17</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>2.188e-03</TD><TD>-6.12</TD><TD>positive regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090336</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.243e-03</TD><TD>-6.10</TD><TD>CNTN2 (contactin 2 (axonal))</TD><TD>protein interactions</TD><TD>6900</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.243e-03</TD><TD>-6.10</TD><TD>ZMIZ1 (zinc finger, MIZ-type containing 1)</TD><TD>protein interactions</TD><TD>57178</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.363e-03</TD><TD>-6.05</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>MSigDB lists</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>6</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.381e-03</TD><TD>-6.04</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,TOX2</TD></TR>
<TR><TD>2.405e-03</TD><TD>-6.03</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,TOX2</TD></TR>
<TR><TD>2.430e-03</TD><TD>-6.02</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>2.450e-03</TD><TD>-6.01</TD><TD>bone-femur-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-other-chondroblastoma</TD><TD>196</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2</TD></TR>
<TR><TD>2.552e-03</TD><TD>-5.97</TD><TD>regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090335</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.552e-03</TD><TD>-5.97</TD><TD>observational learning</TD><TD>biological process</TD><TD>GO:0098597</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.604e-03</TD><TD>-5.95</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>202</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,PLOD2</TD></TR>
<TR><TD>2.676e-03</TD><TD>-5.92</TD><TD>SUN_dom</TD><TD>interpro domains</TD><TD>IPR012919</TD><TD>7</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.741e-03</TD><TD>-5.90</TD><TD>ITGB1BP2 (integrin beta 1 binding protein (melusin) 2)</TD><TD>protein interactions</TD><TD>26548</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.757e-03</TD><TD>-5.89</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</TD><TD>MSigDB lists</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</TD><TD>7</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.757e-03</TD><TD>-5.89</TD><TD>AACTTT_UNKNOWN</TD><TD>MSigDB lists</TD><TD>AACTTT_UNKNOWN</TD><TD>1782</TD><TD>4</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,CNTNAP2,TOX2,MECOM</TD></TR>
<TR><TD>2.786e-03</TD><TD>-5.88</TD><TD>microtubule organizing center attachment site</TD><TD>cellular component</TD><TD>GO:0034992</TD><TD>7</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.786e-03</TD><TD>-5.88</TD><TD>LINC complex</TD><TD>cellular component</TD><TD>GO:0034993</TD><TD>7</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.916e-03</TD><TD>-5.84</TD><TD>neutrophil homeostasis</TD><TD>biological process</TD><TD>GO:0001780</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.916e-03</TD><TD>-5.84</TD><TD>auditory behavior</TD><TD>biological process</TD><TD>GO:0031223</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.916e-03</TD><TD>-5.84</TD><TD>cytoskeletal anchoring at nuclear membrane</TD><TD>biological process</TD><TD>GO:0090286</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.943e-03</TD><TD>-5.83</TD><TD>Sad1_UNC</TD><TD>pfam domains</TD><TD>PF07738</TD><TD>7</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.990e-03</TD><TD>-5.81</TD><TD>SPDEF (SAM pointed domain containing ETS transcription factor)</TD><TD>protein interactions</TD><TD>25803</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.031e-03</TD><TD>-5.80</TD><TD>SUN</TD><TD>prosite domains</TD><TD>PS51469</TD><TD>6</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>3.389e-03</TD><TD>-5.69</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_DN</TD><TD>MSigDB lists</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_DN</TD><TD>231</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,PLOD2</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>COLGALT1 (collagen beta(1-O)galactosyltransferase 1)</TD><TD>protein interactions</TD><TD>79709</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.764e-03</TD><TD>-5.58</TD><TD>Nasopharyngeal carcinoma(PMID:20512145)</TD><TD>GWAS genes</TD><TD>Nasopharyngeal carcinoma(PMID:20512145)</TD><TD>3</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.764e-03</TD><TD>-5.58</TD><TD>Bone mineral density(PMID:17903296)</TD><TD>GWAS genes</TD><TD>Bone mineral density(PMID:17903296)</TD><TD>3</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.936e-03</TD><TD>-5.54</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016706</TD><TD>MSigDB lists</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016706</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.978e-03</TD><TD>-5.53</TD><TD>juxtaparanode region of axon</TD><TD>cellular component</TD><TD>GO:0044224</TD><TD>10</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.994e-03</TD><TD>-5.52</TD><TD>human chr7p12.3</TD><TD>chromosome location</TD><TD>human chr7p12.3</TD><TD>15</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>4.008e-03</TD><TD>-5.52</TD><TD>mechanosensory behavior</TD><TD>biological process</TD><TD>GO:0007638</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.372e-03</TD><TD>-5.43</TD><TD>neuronal ion channel clustering</TD><TD>biological process</TD><TD>GO:0045161</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.525e-03</TD><TD>-5.40</TD><TD>human chr4q32.1</TD><TD>chromosome location</TD><TD>human chr4q32.1</TD><TD>17</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>4.525e-03</TD><TD>-5.40</TD><TD>human chr3q26.2</TD><TD>chromosome location</TD><TD>human chr3q26.2</TD><TD>17</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.736e-03</TD><TD>-5.35</TD><TD>thalamus development</TD><TD>biological process</TD><TD>GO:0021794</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.980e-03</TD><TD>-5.30</TD><TD>KCNA2 (potassium channel, voltage gated shaker related subfamily A, member 2)</TD><TD>protein interactions</TD><TD>3737</TD><TD>20</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.980e-03</TD><TD>-5.30</TD><TD>RNF123 (ring finger protein 123)</TD><TD>protein interactions</TD><TD>63891</TD><TD>20</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.056e-03</TD><TD>-5.29</TD><TD>human chr3q24</TD><TD>chromosome location</TD><TD>human chr3q24</TD><TD>19</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.099e-03</TD><TD>-5.28</TD><TD>vocalization behavior</TD><TD>biological process</TD><TD>GO:0071625</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>5.099e-03</TD><TD>-5.28</TD><TD>hematopoietic stem cell proliferation</TD><TD>biological process</TD><TD>GO:0071425</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.114e-03</TD><TD>-5.28</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>MSigDB lists</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>TPP2 (tripeptidyl peptidase II)</TD><TD>protein interactions</TD><TD>7174</TD><TD>21</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.346e-03</TD><TD>-5.23</TD><TD>Neurexin-like</TD><TD>interpro domains</TD><TD>IPR003585</TD><TD>14</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>5.446e-03</TD><TD>-5.21</TD><TD>protein anchor</TD><TD>molecular function</TD><TD>GO:0043495</TD><TD>15</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>5.477e-03</TD><TD>-5.21</TD><TD>MECOM (MDS1 and EVI1 complex locus)</TD><TD>protein interactions</TD><TD>2122</TD><TD>22</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.609e-03</TD><TD>-5.18</TD><TD>endomembrane system</TD><TD>cellular component</TD><TD>GO:0012505</TD><TD>3658</TD><TD>5</TD><TD>17570</TD><TD>7</TD>
<TD>SUN3,FAM198B,CNTNAP2,PLOD2,MECOM</TD></TR>
<TR><TD>5.758e-03</TD><TD>-5.16</TD><TD>CCCNNGGGAR_V$OLF1_01</TD><TD>MSigDB lists</TD><TD>CCCNNGGGAR_V$OLF1_01</TD><TD>303</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,MECOM</TD></TR>
<TR><TD>5.826e-03</TD><TD>-5.15</TD><TD>striatum development</TD><TD>biological process</TD><TD>GO:0021756</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>6.108e-03</TD><TD>-5.10</TD><TD>Pro_4_hyd_alph</TD><TD>interpro domains</TD><TD>IPR006620</TD><TD>16</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.268e-03</TD><TD>-5.07</TD><TD>Alzheimer&#39;s disease(PMID:22159054)</TD><TD>GWAS genes</TD><TD>Alzheimer&#39;s disease(PMID:22159054)</TD><TD>5</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>6.268e-03</TD><TD>-5.07</TD><TD>Diastolic blood pressure(PMID:19430483)</TD><TD>GWAS genes</TD><TD>Diastolic blood pressure(PMID:19430483)</TD><TD>5</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>6.423e-03</TD><TD>-5.05</TD><TD>TGANTCA_V$AP1_C</TD><TD>MSigDB lists</TD><TD>TGANTCA_V$AP1_C</TD><TD>1074</TD><TD>3</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,CNTNAP2,MECOM</TD></TR>
<TR><TD>6.470e-03</TD><TD>-5.04</TD><TD>NUSAP1 (nucleolar and spindle associated protein 1)</TD><TD>protein interactions</TD><TD>51203</TD><TD>26</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.552e-03</TD><TD>-5.03</TD><TD>pericardium development</TD><TD>biological process</TD><TD>GO:0060039</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>6.620e-03</TD><TD>-5.02</TD><TD>forebrain development</TD><TD>biological process</TD><TD>GO:0030900</TD><TD>356</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>6.677e-03</TD><TD>-5.01</TD><TD>central_nervous_system-diencephalon-glioma-astrocytoma_Grade_I</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-diencephalon-glioma-astrocytoma_Grade_I</TD><TD>17</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>6.683e-03</TD><TD>-5.01</TD><TD>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</TD><TD>MSigDB lists</TD><TD>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>6.718e-03</TD><TD>-5.00</TD><TD>DNPEP (aspartyl aminopeptidase)</TD><TD>protein interactions</TD><TD>23549</TD><TD>27</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.785e-03</TD><TD>-4.99</TD><TD>typical</TD><TD>COSMIC cancer mutations</TD><TD>typical</TD><TD>330</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2</TD></TR>
<TR><TD>6.785e-03</TD><TD>-4.99</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>330</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2</TD></TR>
<TR><TD>6.915e-03</TD><TD>-4.97</TD><TD>response to auditory stimulus</TD><TD>biological process</TD><TD>GO:0010996</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>7.068e-03</TD><TD>-4.95</TD><TD>diencephalon</TD><TD>COSMIC cancer mutations</TD><TD>diencephalon</TD><TD>18</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>7.075e-03</TD><TD>-4.95</TD><TD>MODULE_478</TD><TD>MSigDB lists</TD><TD>MODULE_478</TD><TD>18</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.151e-03</TD><TD>-4.94</TD><TD>axolemma</TD><TD>cellular component</TD><TD>GO:0030673</TD><TD>18</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>7.215e-03</TD><TD>-4.93</TD><TD>SWAP70 (SWAP switching B-cell complex 70kDa subunit)</TD><TD>protein interactions</TD><TD>23075</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.463e-03</TD><TD>-4.90</TD><TD>VASN (vasorin)</TD><TD>protein interactions</TD><TD>114990</TD><TD>30</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.467e-03</TD><TD>-4.90</TD><TD>chr3q24</TD><TD>MSigDB lists</TD><TD>chr3q24</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.467e-03</TD><TD>-4.90</TD><TD>chr7p12</TD><TD>MSigDB lists</TD><TD>chr7p12</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>SUN3</TD></TR>
<TR><TD>7.519e-03</TD><TD>-4.89</TD><TD>Magnesium levels(PMID:20700443)</TD><TD>GWAS genes</TD><TD>Magnesium levels(PMID:20700443)</TD><TD>6</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.519e-03</TD><TD>-4.89</TD><TD>Conduct disorder (symptom count)(PMID:20585324)</TD><TD>GWAS genes</TD><TD>Conduct disorder (symptom count)(PMID:20585324)</TD><TD>6</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>TOX2</TD></TR>
<TR><TD>7.546e-03</TD><TD>-4.89</TD><TD>rough endoplasmic reticulum membrane</TD><TD>cellular component</TD><TD>GO:0030867</TD><TD>19</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.617e-03</TD><TD>-4.88</TD><TD>L-ascorbic acid binding</TD><TD>molecular function</TD><TD>GO:0031418</TD><TD>21</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.644e-03</TD><TD>-4.87</TD><TD>4.1m</TD><TD>smart domains</TD><TD>SM00294</TD><TD>14</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>8.003e-03</TD><TD>-4.83</TD><TD>subpallium development</TD><TD>biological process</TD><TD>GO:0021544</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>8.010e-03</TD><TD>-4.83</TD><TD>Oxoglu/Fe-dep_dioxygenase</TD><TD>interpro domains</TD><TD>IPR005123</TD><TD>21</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.065e-03</TD><TD>-4.82</TD><TD>FA58C_2</TD><TD>prosite domains</TD><TD>PS01286</TD><TD>16</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>8.250e-03</TD><TD>-4.80</TD><TD>HUI_MAPK14_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HUI_MAPK14_TARGETS_UP</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>8.250e-03</TD><TD>-4.80</TD><TD>NUMATA_CSF3_SIGNALING_VIA_STAT3</TD><TD>MSigDB lists</TD><TD>NUMATA_CSF3_SIGNALING_VIA_STAT3</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.455e-03</TD><TD>-4.77</TD><TD>CSDE1 (cold shock domain containing E1, RNA binding)</TD><TD>protein interactions</TD><TD>7812</TD><TD>34</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.512e-03</TD><TD>-4.77</TD><TD>pleura-mesothelioma-epithelial</TD><TD>COSMIC cancer mutations</TD><TD>pleura-mesothelioma-epithelial</TD><TD>371</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>8.601e-03</TD><TD>-4.76</TD><TD>epithelial</TD><TD>COSMIC cancer mutations</TD><TD>epithelial</TD><TD>373</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>8.703e-03</TD><TD>-4.74</TD><TD>FARSB (phenylalanyl-tRNA synthetase beta subunit)</TD><TD>protein interactions</TD><TD>10056</TD><TD>35</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.733e-03</TD><TD>-4.74</TD><TD>P4Hc</TD><TD>smart domains</TD><TD>SM00702</TD><TD>16</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.768e-03</TD><TD>-4.74</TD><TD>Systolic blood pressure(PMID:19430479)</TD><TD>GWAS genes</TD><TD>Systolic blood pressure(PMID:19430479)</TD><TD>7</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.769e-03</TD><TD>-4.74</TD><TD>FA58C</TD><TD>interpro domains</TD><TD>IPR000421</TD><TD>23</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>8.887e-03</TD><TD>-4.72</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>379</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>8.950e-03</TD><TD>-4.72</TD><TD>PRMT3 (protein arginine methyltransferase 3)</TD><TD>protein interactions</TD><TD>10196</TD><TD>36</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.069e-03</TD><TD>-4.70</TD><TD>FA58C_1</TD><TD>prosite domains</TD><TD>PS01285</TD><TD>18</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>9.090e-03</TD><TD>-4.70</TD><TD>response to gonadotropin</TD><TD>biological process</TD><TD>GO:0034698</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>9.424e-03</TD><TD>-4.66</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</TD><TD>MSigDB lists</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.446e-03</TD><TD>-4.66</TD><TD>CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component)</TD><TD>protein interactions</TD><TD>9646</TD><TD>38</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>9.644e-03</TD><TD>-4.64</TD><TD>F5_F8_type_C</TD><TD>pfam domains</TD><TD>PF00754</TD><TD>23</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>9.805e-03</TD><TD>-4.62</TD><TD>bone-humerus-chondrosarcoma-central</TD><TD>COSMIC cancer mutations</TD><TD>bone-humerus-chondrosarcoma-central</TD><TD>25</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.002e-02</TD><TD>-4.60</TD><TD>Immune reponse to smallpox (secreted IL-1beta)(PMID:22610502)</TD><TD>GWAS genes</TD><TD>Immune reponse to smallpox (secreted IL-1beta)(PMID:22610502)</TD><TD>8</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.009e-02</TD><TD>-4.60</TD><TD>human chr7q35</TD><TD>chromosome location</TD><TD>human chr7q35</TD><TD>38</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.019e-02</TD><TD>-4.59</TD><TD>PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2)</TD><TD>protein interactions</TD><TD>5352</TD><TD>41</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.021e-02</TD><TD>-4.58</TD><TD>VALK_AML_CLUSTER_1</TD><TD>MSigDB lists</TD><TD>VALK_AML_CLUSTER_1</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.054e-02</TD><TD>-4.55</TD><TD>embryonic hindlimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035116</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.057e-02</TD><TD>-4.55</TD><TD>FA58C_3</TD><TD>prosite domains</TD><TD>PS50022</TD><TD>21</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.057e-02</TD><TD>-4.55</TD><TD>FE2OG_OXY</TD><TD>prosite domains</TD><TD>PS51471</TD><TD>21</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.060e-02</TD><TD>-4.55</TD><TD>RESPONSE_TO_HYPOXIA</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_HYPOXIA</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.060e-02</TD><TD>-4.55</TD><TD>WOTTON_RUNX_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>WOTTON_RUNX_TARGETS_DN</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.068e-02</TD><TD>-4.54</TD><TD>RANBP3 (RAN binding protein 3)</TD><TD>protein interactions</TD><TD>8498</TD><TD>43</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.093e-02</TD><TD>-4.52</TD><TD>PACSIN2 (protein kinase C and casein kinase substrate in neurons 2)</TD><TD>protein interactions</TD><TD>11252</TD><TD>44</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.126e-02</TD><TD>-4.49</TD><TD>neuron maturation</TD><TD>biological process</TD><TD>GO:0042551</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.138e-02</TD><TD>-4.48</TD><TD>chr7q35</TD><TD>MSigDB lists</TD><TD>chr7q35</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.145e-02</TD><TD>-4.47</TD><TD>FA58C</TD><TD>smart domains</TD><TD>SM00231</TD><TD>21</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>neuron recognition</TD><TD>biological process</TD><TD>GO:0008038</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>negative regulation of JNK cascade</TD><TD>biological process</TD><TD>GO:0046329</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</TD><TD>MSigDB lists</TD><TD>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</TD><TD>436</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>ZNF432,FAM198B</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>4353</TD><TD>5</TD><TD>17775</TD><TD>7</TD>
<TD>SUN3,ZNF432,CNTNAP2,PLOD2,TOX2</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>MACF1 (microtubule-actin crosslinking factor 1)</TD><TD>protein interactions</TD><TD>23499</TD><TD>48</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>SAMHD1 (SAM domain and HD domain 1)</TD><TD>protein interactions</TD><TD>25939</TD><TD>48</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.210e-02</TD><TD>-4.41</TD><TD>ONDER_CDH1_TARGETS_2_DN</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_TARGETS_2_DN</TD><TD>445</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>GNF2_MMP1</TD><TD>MSigDB lists</TD><TD>GNF2_MMP1</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>ROZANOV_MMP14_TARGETS_SUBSET</TD><TD>MSigDB lists</TD><TD>ROZANOV_MMP14_TARGETS_SUBSET</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.218e-02</TD><TD>-4.41</TD><TD>Fibrinogen_a/b/g_C_dom</TD><TD>interpro domains</TD><TD>IPR002181</TD><TD>32</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.235e-02</TD><TD>-4.39</TD><TD>embryonic forelimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035115</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.241e-02</TD><TD>-4.39</TD><TD>NARS (asparaginyl-tRNA synthetase)</TD><TD>protein interactions</TD><TD>4677</TD><TD>50</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.251e-02</TD><TD>-4.38</TD><TD>Renal function-related traits (BUN)(PMID:22797727)</TD><TD>GWAS genes</TD><TD>Renal function-related traits (BUN)(PMID:22797727)</TD><TD>10</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.255e-02</TD><TD>-4.38</TD><TD>GRADE_COLON_CANCER_DN</TD><TD>MSigDB lists</TD><TD>GRADE_COLON_CANCER_DN</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.266e-02</TD><TD>-4.37</TD><TD>UGP2 (UDP-glucose pyrophosphorylase 2)</TD><TD>protein interactions</TD><TD>7360</TD><TD>51</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.291e-02</TD><TD>-4.35</TD><TD>GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase)</TD><TD>protein interactions</TD><TD>2618</TD><TD>52</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.291e-02</TD><TD>-4.35</TD><TD>PTPN12 (protein tyrosine phosphatase, non-receptor type 12)</TD><TD>protein interactions</TD><TD>5782</TD><TD>52</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.294e-02</TD><TD>-4.35</TD><TD>DOANE_BREAST_CANCER_CLASSES_DN</TD><TD>MSigDB lists</TD><TD>DOANE_BREAST_CANCER_CLASSES_DN</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.294e-02</TD><TD>-4.35</TD><TD>VALK_AML_CLUSTER_5</TD><TD>MSigDB lists</TD><TD>VALK_AML_CLUSTER_5</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>1.308e-02</TD><TD>-4.34</TD><TD>aggresome</TD><TD>cellular component</TD><TD>GO:0016235</TD><TD>33</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.372e-02</TD><TD>-4.29</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016705</TD><TD>MSigDB lists</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016705</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.376e-02</TD><TD>-4.29</TD><TD>Diastolic blood pressure(PMID:21909115)</TD><TD>GWAS genes</TD><TD>Diastolic blood pressure(PMID:21909115)</TD><TD>11</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.379e-02</TD><TD>-4.28</TD><TD>hindlimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035137</TD><TD>38</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.411e-02</TD><TD>-4.26</TD><TD>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</TD><TD>MSigDB lists</TD><TD>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.411e-02</TD><TD>-4.26</TD><TD>GNF2_PTX3</TD><TD>MSigDB lists</TD><TD>GNF2_PTX3</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.415e-02</TD><TD>-4.26</TD><TD>negative regulation of stress-activated protein kinase signaling cascade</TD><TD>biological process</TD><TD>GO:0070303</TD><TD>39</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.415e-02</TD><TD>-4.26</TD><TD>negative regulation of stress-activated MAPK cascade</TD><TD>biological process</TD><TD>GO:0032873</TD><TD>39</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>488</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2</TD></TR>
<TR><TD>1.450e-02</TD><TD>-4.23</TD><TD>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</TD><TD>MSigDB lists</TD><TD>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</TD><TD>37</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.464e-02</TD><TD>-4.22</TD><TD>Laminin_G_2</TD><TD>pfam domains</TD><TD>PF02210</TD><TD>35</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.473e-02</TD><TD>-4.22</TD><TD>organelle organization</TD><TD>biological process</TD><TD>GO:0006996</TD><TD>3164</TD><TD>4</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>1.484e-02</TD><TD>-4.21</TD><TD>human chr19q13.41</TD><TD>chromosome location</TD><TD>human chr19q13.41</TD><TD>56</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>ZNF432</TD></TR>
<TR><TD>1.500e-02</TD><TD>-4.20</TD><TD>Systolic blood pressure(PMID:21909115)</TD><TD>GWAS genes</TD><TD>Systolic blood pressure(PMID:21909115)</TD><TD>12</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.501e-02</TD><TD>-4.20</TD><TD>Golgi apparatus</TD><TD>cellular component</TD><TD>GO:0005794</TD><TD>1442</TD><TD>3</TD><TD>17570</TD><TD>7</TD>
<TD>FAM198B,CNTNAP2,MECOM</TD></TR>
<TR><TD>1.507e-02</TD><TD>-4.20</TD><TD>LIAO_METASTASIS</TD><TD>MSigDB lists</TD><TD>LIAO_METASTASIS</TD><TD>499</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>1.513e-02</TD><TD>-4.19</TD><TD>OS9 (osteosarcoma amplified 9, endoplasmic reticulum lectin)</TD><TD>protein interactions</TD><TD>10956</TD><TD>61</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.523e-02</TD><TD>-4.18</TD><TD>forelimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035136</TD><TD>42</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.544e-02</TD><TD>-4.17</TD><TD>neuron projection membrane</TD><TD>cellular component</TD><TD>GO:0032589</TD><TD>39</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.575e-02</TD><TD>-4.15</TD><TD>cellular component organization</TD><TD>biological process</TD><TD>GO:0016043</TD><TD>5336</TD><TD>5</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3,CNTNAP2,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>1.583e-02</TD><TD>-4.15</TD><TD>WGTTNNNNNAAA_UNKNOWN</TD><TD>MSigDB lists</TD><TD>WGTTNNNNNAAA_UNKNOWN</TD><TD>512</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>1.589e-02</TD><TD>-4.14</TD><TD>human chr20q13.12</TD><TD>chromosome location</TD><TD>human chr20q13.12</TD><TD>60</TD><TD>1</TD><TD>26250</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>1.605e-02</TD><TD>-4.13</TD><TD>KEGG_LYSINE_DEGRADATION</TD><TD>MSigDB lists</TD><TD>KEGG_LYSINE_DEGRADATION</TD><TD>41</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.608e-02</TD><TD>-4.13</TD><TD>FIBRINOGEN_C_2</TD><TD>prosite domains</TD><TD>PS51406</TD><TD>32</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors</TD><TD>molecular function</TD><TD>GO:0016706</TD><TD>45</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.633e-02</TD><TD>-4.11</TD><TD>skin-ear-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-ear-carcinoma-squamous_cell_carcinoma</TD><TD>521</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>1.644e-02</TD><TD>-4.11</TD><TD>JAEGER_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>JAEGER_METASTASIS_UP</TD><TD>42</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.667e-02</TD><TD>-4.09</TD><TD>intraspecies interaction between organisms</TD><TD>biological process</TD><TD>GO:0051703</TD><TD>46</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.667e-02</TD><TD>-4.09</TD><TD>social behavior</TD><TD>biological process</TD><TD>GO:0035176</TD><TD>46</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.686e-02</TD><TD>-4.08</TD><TD>GANAB (glucosidase, alpha; neutral AB)</TD><TD>protein interactions</TD><TD>23193</TD><TD>68</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.686e-02</TD><TD>-4.08</TD><TD>XPO7 (exportin 7)</TD><TD>protein interactions</TD><TD>23039</TD><TD>68</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.696e-02</TD><TD>-4.08</TD><TD>CHICAS_RB1_TARGETS_CONFLUENT</TD><TD>MSigDB lists</TD><TD>CHICAS_RB1_TARGETS_CONFLUENT</TD><TD>531</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,MECOM</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>MBD3 (methyl-CpG binding domain protein 3)</TD><TD>protein interactions</TD><TD>53615</TD><TD>69</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.722e-02</TD><TD>-4.06</TD><TD>RICKMAN_HEAD_AND_NECK_CANCER_B</TD><TD>MSigDB lists</TD><TD>RICKMAN_HEAD_AND_NECK_CANCER_B</TD><TD>44</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.722e-02</TD><TD>-4.06</TD><TD>PARK_HSC_MARKERS</TD><TD>MSigDB lists</TD><TD>PARK_HSC_MARKERS</TD><TD>44</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.722e-02</TD><TD>-4.06</TD><TD>ZHAN_MULTIPLE_MYELOMA_CD1_UP</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_CD1_UP</TD><TD>44</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>1.739e-02</TD><TD>-4.05</TD><TD>positive regulation of fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045600</TD><TD>48</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.749e-02</TD><TD>-4.05</TD><TD>Visceral adipose tissue/subcutaneous adipose tissue ratio(PMID:22589738)</TD><TD>GWAS genes</TD><TD>Visceral adipose tissue/subcutaneous adipose tissue ratio(PMID:22589738)</TD><TD>14</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.757e-02</TD><TD>-4.04</TD><TD>LAM_G_DOMAIN</TD><TD>prosite domains</TD><TD>PS50025</TD><TD>35</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.761e-02</TD><TD>-4.04</TD><TD>WARTERS_IR_RESPONSE_5GY</TD><TD>MSigDB lists</TD><TD>WARTERS_IR_RESPONSE_5GY</TD><TD>45</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>1.763e-02</TD><TD>-4.04</TD><TD>cellular component organization or biogenesis</TD><TD>biological process</TD><TD>GO:0071840</TD><TD>5468</TD><TD>5</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3,CNTNAP2,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>1.826e-02</TD><TD>-4.00</TD><TD>zf-C2H2</TD><TD>pfam domains</TD><TD>PF00096</TD><TD>517</TD><TD>2</TD><TD>16629</TD><TD>7</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>1.873e-02</TD><TD>-3.98</TD><TD>chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>chondroblastoma</TD><TD>560</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2</TD></TR>
<TR><TD>1.875e-02</TD><TD>-3.98</TD><TD>haematopoietic_and_lymphoid_tissue-breast-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-breast-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>48</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.877e-02</TD><TD>-3.98</TD><TD>BILBAN_B_CLL_LPL_DN</TD><TD>MSigDB lists</TD><TD>BILBAN_B_CLL_LPL_DN</TD><TD>48</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.907e-02</TD><TD>-3.96</TD><TD>CASK (calcium/calmodulin-dependent serine protein kinase (MAGUK family))</TD><TD>protein interactions</TD><TD>8573</TD><TD>77</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>1.907e-02</TD><TD>-3.96</TD><TD>SEC23A (Sec23 homolog A, COPII coat complex component)</TD><TD>protein interactions</TD><TD>10484</TD><TD>77</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.916e-02</TD><TD>-3.95</TD><TD>FRASOR_TAMOXIFEN_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>FRASOR_TAMOXIFEN_RESPONSE_UP</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.916e-02</TD><TD>-3.95</TD><TD>MODULE_61</TD><TD>MSigDB lists</TD><TD>MODULE_61</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.916e-02</TD><TD>-3.95</TD><TD>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</TD><TD>MSigDB lists</TD><TD>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.916e-02</TD><TD>-3.95</TD><TD>SU_PANCREAS</TD><TD>MSigDB lists</TD><TD>SU_PANCREAS</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.936e-02</TD><TD>-3.94</TD><TD>SET_dom</TD><TD>interpro domains</TD><TD>IPR001214</TD><TD>51</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.962e-02</TD><TD>-3.93</TD><TD>HMG_box</TD><TD>pfam domains</TD><TD>PF00505</TD><TD>47</TD><TD>1</TD><TD>16629</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.032e-02</TD><TD>-3.90</TD><TD>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</TD><TD>52</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.041e-02</TD><TD>-3.89</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>586</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>2.048e-02</TD><TD>-3.89</TD><TD>HMG_box_dom</TD><TD>interpro domains</TD><TD>IPR009071</TD><TD>54</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.054e-02</TD><TD>-3.89</TD><TD>left_upper_lobe</TD><TD>COSMIC cancer mutations</TD><TD>left_upper_lobe</TD><TD>588</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>2.071e-02</TD><TD>-3.88</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</TD><TD>53</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.071e-02</TD><TD>-3.88</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_DN</TD><TD>MSigDB lists</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_DN</TD><TD>53</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.079e-02</TD><TD>-3.87</TD><TD>HSPH1 (heat shock 105kDa/110kDa protein 1)</TD><TD>protein interactions</TD><TD>10808</TD><TD>84</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.104e-02</TD><TD>-3.86</TD><TD>AP2B1 (adaptor-related protein complex 2, beta 1 subunit)</TD><TD>protein interactions</TD><TD>163</TD><TD>85</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.110e-02</TD><TD>-3.86</TD><TD>MODULE_175</TD><TD>MSigDB lists</TD><TD>MODULE_175</TD><TD>54</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.110e-02</TD><TD>-3.86</TD><TD>REACTOME_COLLAGEN_FORMATION</TD><TD>MSigDB lists</TD><TD>REACTOME_COLLAGEN_FORMATION</TD><TD>54</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.124e-02</TD><TD>-3.85</TD><TD>brain development</TD><TD>biological process</TD><TD>GO:0007420</TD><TD>653</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>2.131e-02</TD><TD>-3.85</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>1659</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,FAM198B,MECOM</TD></TR>
<TR><TD>2.134e-02</TD><TD>-3.85</TD><TD>transmission of nerve impulse</TD><TD>biological process</TD><TD>GO:0019226</TD><TD>59</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.187e-02</TD><TD>-3.82</TD><TD>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</TD><TD>MSigDB lists</TD><TD>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</TD><TD>56</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.187e-02</TD><TD>-3.82</TD><TD>MODULE_350</TD><TD>MSigDB lists</TD><TD>MODULE_350</TD><TD>56</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Laminin_G</TD><TD>interpro domains</TD><TD>IPR001791</TD><TD>58</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.202e-02</TD><TD>-3.82</TD><TD>CTBP2 (C-terminal binding protein 2)</TD><TD>protein interactions</TD><TD>1488</TD><TD>89</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.206e-02</TD><TD>-3.81</TD><TD>stem cell proliferation</TD><TD>biological process</TD><TD>GO:0072089</TD><TD>61</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.210e-02</TD><TD>-3.81</TD><TD>main axon</TD><TD>cellular component</TD><TD>GO:0044304</TD><TD>56</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.81</TD><TD>chr3q26</TD><TD>MSigDB lists</TD><TD>chr3q26</TD><TD>57</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.81</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</TD><TD>57</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>EPB41L3 (erythrocyte membrane protein band 4.1-like 3)</TD><TD>protein interactions</TD><TD>23136</TD><TD>90</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.242e-02</TD><TD>-3.80</TD><TD>Lysine degradation</TD><TD>KEGG pathways</TD><TD>hsa00310</TD><TD>52</TD><TD>1</TD><TD>6908</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.242e-02</TD><TD>-3.80</TD><TD>Lysine degradation</TD><TD>KEGG pathways</TD><TD>ko00310</TD><TD>52</TD><TD>1</TD><TD>6908</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.244e-02</TD><TD>-3.80</TD><TD>Pulmonary function(PMID:21946350)</TD><TD>GWAS genes</TD><TD>Pulmonary function(PMID:21946350)</TD><TD>18</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.264e-02</TD><TD>-3.79</TD><TD>NAKAMURA_ADIPOGENESIS_EARLY_UP</TD><TD>MSigDB lists</TD><TD>NAKAMURA_ADIPOGENESIS_EARLY_UP</TD><TD>58</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>2.313e-02</TD><TD>-3.77</TD><TD>leukocyte homeostasis</TD><TD>biological process</TD><TD>GO:0001776</TD><TD>64</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.323e-02</TD><TD>-3.76</TD><TD>PKMTs methylate histone lysines</TD><TD>REACTOME pathways</TD><TD>R-HSA-3214841</TD><TD>64</TD><TD>1</TD><TD>8202</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.323e-02</TD><TD>-3.76</TD><TD>Collagen biosynthesis and modifying enzymes</TD><TD>REACTOME pathways</TD><TD>R-HSA-1650814</TD><TD>64</TD><TD>1</TD><TD>8202</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.324e-02</TD><TD>-3.76</TD><TD>PIAS4 (protein inhibitor of activated STAT 4)</TD><TD>protein interactions</TD><TD>51588</TD><TD>94</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.327e-02</TD><TD>-3.76</TD><TD>histone deacetylase complex</TD><TD>cellular component</TD><TD>GO:0000118</TD><TD>59</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.332e-02</TD><TD>-3.76</TD><TD>chromatin organization</TD><TD>biological process</TD><TD>GO:0006325</TD><TD>686</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>2.377e-02</TD><TD>-3.74</TD><TD>head development</TD><TD>biological process</TD><TD>GO:0060322</TD><TD>693</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>2.378e-02</TD><TD>-3.74</TD><TD>central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV</TD><TD>61</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.387e-02</TD><TD>-3.74</TD><TD>LamG</TD><TD>smart domains</TD><TD>SM00282</TD><TD>44</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.398e-02</TD><TD>-3.73</TD><TD>EHMT2 (euchromatic histone-lysine N-methyltransferase 2)</TD><TD>protein interactions</TD><TD>10919</TD><TD>97</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.419e-02</TD><TD>-3.72</TD><TD>KYNG_DNA_DAMAGE_BY_UV</TD><TD>MSigDB lists</TD><TD>KYNG_DNA_DAMAGE_BY_UV</TD><TD>62</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.419e-02</TD><TD>-3.72</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</TD><TD>62</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.424e-02</TD><TD>-3.72</TD><TD>ear</TD><TD>COSMIC cancer mutations</TD><TD>ear</TD><TD>642</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2</TD></TR>
<TR><TD>2.443e-02</TD><TD>-3.71</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</TD><TD>MSigDB lists</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</TD><TD>644</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>2.453e-02</TD><TD>-3.71</TD><TD>HMG_BOX_2</TD><TD>prosite domains</TD><TD>PS50118</TD><TD>49</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.458e-02</TD><TD>-3.71</TD><TD>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</TD><TD>63</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.485e-02</TD><TD>-3.70</TD><TD>monosaccharide binding</TD><TD>molecular function</TD><TD>GO:0048029</TD><TD>69</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.492e-02</TD><TD>-3.69</TD><TD>Blood pressure(PMID:21909110)</TD><TD>GWAS genes</TD><TD>Blood pressure(PMID:21909110)</TD><TD>20</TD><TD>1</TD><TD>2389</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.507e-02</TD><TD>-3.69</TD><TD>SMID_BREAST_CANCER_BASAL_DN</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_BASAL_DN</TD><TD>653</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,CNTNAP2</TD></TR>
<TR><TD>2.520e-02</TD><TD>-3.68</TD><TD>SET (SET nuclear proto-oncogene)</TD><TD>protein interactions</TD><TD>6418</TD><TD>102</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.535e-02</TD><TD>-3.68</TD><TD>AAGTCCA,MIR-422B,MIR-422A</TD><TD>MSigDB lists</TD><TD>AAGTCCA,MIR-422B,MIR-422A</TD><TD>65</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.535e-02</TD><TD>-3.68</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>MSigDB lists</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>65</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.548e-02</TD><TD>-3.67</TD><TD>SET</TD><TD>smart domains</TD><TD>SM00317</TD><TD>47</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.552e-02</TD><TD>-3.67</TD><TD>SET</TD><TD>prosite domains</TD><TD>PS50280</TD><TD>51</TD><TD>1</TD><TD>11866</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.552e-02</TD><TD>-3.67</TD><TD>Znf_C2H2/integrase_DNA-bd</TD><TD>interpro domains</TD><TD>IPR013087</TD><TD>679</TD><TD>2</TD><TD>18293</TD><TD>7</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>2.569e-02</TD><TD>-3.66</TD><TD>FAF1 (Fas (TNFRSF6) associated factor 1)</TD><TD>protein interactions</TD><TD>11124</TD><TD>104</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.574e-02</TD><TD>-3.66</TD><TD>intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>intestinal_adenocarcinoma</TD><TD>7530</TD><TD>6</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,CNTNAP2,FAM198B,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>2.574e-02</TD><TD>-3.66</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>7530</TD><TD>6</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,CNTNAP2,FAM198B,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.30.10</TD><TD>52</TD><TD>1</TD><TD>9988</TD><TD>5</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.580e-02</TD><TD>-3.66</TD><TD>lymph_node</TD><TD>COSMIC cancer mutations</TD><TD>lymph_node</TD><TD>1781</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,CNTNAP2,PLOD2</TD></TR>
<TR><TD>2.587e-02</TD><TD>-3.65</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>MSigDB lists</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>1781</TD><TD>3</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2,PLOD2,MECOM</TD></TR>
<TR><TD>2.600e-02</TD><TD>-3.65</TD><TD>rough endoplasmic reticulum</TD><TD>cellular component</TD><TD>GO:0005791</TD><TD>66</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.609e-02</TD><TD>-3.65</TD><TD>cerebrum</TD><TD>COSMIC cancer mutations</TD><TD>cerebrum</TD><TD>67</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.635e-02</TD><TD>-3.64</TD><TD>diencephalon development</TD><TD>biological process</TD><TD>GO:0021536</TD><TD>73</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.635e-02</TD><TD>-3.64</TD><TD>nuclear envelope organization</TD><TD>biological process</TD><TD>GO:0006998</TD><TD>73</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>SUPT5H (SPT5 homolog, DSIF elongation factor subunit)</TD><TD>protein interactions</TD><TD>6829</TD><TD>107</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>ROSS_AML_OF_FAB_M7_TYPE</TD><TD>MSigDB lists</TD><TD>ROSS_AML_OF_FAB_M7_TYPE</TD><TD>68</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.671e-02</TD><TD>-3.62</TD><TD>negative regulation of transforming growth factor beta receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030512</TD><TD>74</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.671e-02</TD><TD>-3.62</TD><TD>negative regulation of cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:1903845</TD><TD>74</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.716e-02</TD><TD>-3.61</TD><TD>JUP (junction plakoglobin)</TD><TD>protein interactions</TD><TD>3728</TD><TD>110</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.727e-02</TD><TD>-3.60</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>70</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.762e-02</TD><TD>-3.59</TD><TD>HMG</TD><TD>smart domains</TD><TD>SM00398</TD><TD>51</TD><TD>1</TD><TD>9131</TD><TD>5</TD>
<TD>TOX2</TD></TR>
<TR><TD>2.766e-02</TD><TD>-3.59</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>71</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.766e-02</TD><TD>-3.59</TD><TD>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</TD><TD>MSigDB lists</TD><TD>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</TD><TD>71</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>inclusion body</TD><TD>cellular component</TD><TD>GO:0016234</TD><TD>71</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.802e-02</TD><TD>-3.57</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-granular_cell_tumour</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-granular_cell_tumour</TD><TD>72</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.802e-02</TD><TD>-3.57</TD><TD>granular_cell_tumour</TD><TD>COSMIC cancer mutations</TD><TD>granular_cell_tumour</TD><TD>72</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.804e-02</TD><TD>-3.57</TD><TD>MODULE_120</TD><TD>MSigDB lists</TD><TD>MODULE_120</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.804e-02</TD><TD>-3.57</TD><TD>COATES_MACROPHAGE_M1_VS_M2_DN</TD><TD>MSigDB lists</TD><TD>COATES_MACROPHAGE_M1_VS_M2_DN</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>2.804e-02</TD><TD>-3.57</TD><TD>WARTERS_RESPONSE_TO_IR_SKIN</TD><TD>MSigDB lists</TD><TD>WARTERS_RESPONSE_TO_IR_SKIN</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>2.804e-02</TD><TD>-3.57</TD><TD>CROONQUIST_NRAS_SIGNALING_DN</TD><TD>MSigDB lists</TD><TD>CROONQUIST_NRAS_SIGNALING_DN</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.841e-02</TD><TD>-3.56</TD><TD>vitamin binding</TD><TD>molecular function</TD><TD>GO:0019842</TD><TD>79</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.843e-02</TD><TD>-3.56</TD><TD>KEGG_CHRONIC_MYELOID_LEUKEMIA</TD><TD>MSigDB lists</TD><TD>KEGG_CHRONIC_MYELOID_LEUKEMIA</TD><TD>73</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>74</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.901e-02</TD><TD>-3.54</TD><TD>intracellular membrane-bounded organelle</TD><TD>cellular component</TD><TD>GO:0043231</TD><TD>10597</TD><TD>7</TD><TD>17570</TD><TD>7</TD>
<TD>SUN3,ZNF432,FAM198B,CNTNAP2,PLOD2,TOX2,MECOM</TD></TR>
<TR><TD>2.913e-02</TD><TD>-3.54</TD><TD>CTTTGT_V$LEF1_Q2</TD><TD>MSigDB lists</TD><TD>CTTTGT_V$LEF1_Q2</TD><TD>1862</TD><TD>3</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B,PLOD2,TOX2</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>SF1 (splicing factor 1)</TD><TD>protein interactions</TD><TD>7536</TD><TD>119</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.947e-02</TD><TD>-3.52</TD><TD>Galactose-bd-like</TD><TD>interpro domains</TD><TD>IPR008979</TD><TD>78</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.956e-02</TD><TD>-3.52</TD><TD>maintenance of protein location in cell</TD><TD>biological process</TD><TD>GO:0032507</TD><TD>82</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.958e-02</TD><TD>-3.52</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>MSigDB lists</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>76</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.958e-02</TD><TD>-3.52</TD><TD>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</TD><TD>MSigDB lists</TD><TD>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</TD><TD>76</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.991e-02</TD><TD>-3.51</TD><TD>multi-organism behavior</TD><TD>biological process</TD><TD>GO:0051705</TD><TD>83</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.997e-02</TD><TD>-3.51</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>MSigDB lists</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>77</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.002e-02</TD><TD>-3.51</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>719</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.011e-02</TD><TD>-3.50</TD><TD>single-organism membrane organization</TD><TD>biological process</TD><TD>GO:0044802</TD><TD>786</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3,CNTNAP2</TD></TR>
<TR><TD>3.035e-02</TD><TD>-3.49</TD><TD>MODULE_243</TD><TD>MSigDB lists</TD><TD>MODULE_243</TD><TD>78</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>3.073e-02</TD><TD>-3.48</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>MSigDB lists</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>79</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.112e-02</TD><TD>-3.47</TD><TD>BASSO_HAIRY_CELL_LEUKEMIA_DN</TD><TD>MSigDB lists</TD><TD>BASSO_HAIRY_CELL_LEUKEMIA_DN</TD><TD>80</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.113e-02</TD><TD>-3.47</TD><TD>Collagen formation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1474290</TD><TD>86</TD><TD>1</TD><TD>8202</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.137e-02</TD><TD>-3.46</TD><TD>Chronic myeloid leukemia</TD><TD>KEGG pathways</TD><TD>ko05220</TD><TD>73</TD><TD>1</TD><TD>6908</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.137e-02</TD><TD>-3.46</TD><TD>Chronic myeloid leukemia</TD><TD>KEGG pathways</TD><TD>hsa05220</TD><TD>73</TD><TD>1</TD><TD>6908</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.150e-02</TD><TD>-3.46</TD><TD>CTGYNNCTYTAA_UNKNOWN</TD><TD>MSigDB lists</TD><TD>CTGYNNCTYTAA_UNKNOWN</TD><TD>81</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.160e-02</TD><TD>-3.45</TD><TD>dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0051213</TD><TD>88</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.188e-02</TD><TD>-3.45</TD><TD>SANA_RESPONSE_TO_IFNG_DN</TD><TD>MSigDB lists</TD><TD>SANA_RESPONSE_TO_IFNG_DN</TD><TD>82</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>3.188e-02</TD><TD>-3.45</TD><TD>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</TD><TD>MSigDB lists</TD><TD>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</TD><TD>82</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>3.188e-02</TD><TD>-3.45</TD><TD>TCTGGAC,MIR-198</TD><TD>MSigDB lists</TD><TD>TCTGGAC,MIR-198</TD><TD>82</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.197e-02</TD><TD>-3.44</TD><TD>Znf_C2H2</TD><TD>interpro domains</TD><TD>IPR007087</TD><TD>766</TD><TD>2</TD><TD>18293</TD><TD>7</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>3.205e-02</TD><TD>-3.44</TD><TD>maintenance of protein location</TD><TD>biological process</TD><TD>GO:0045185</TD><TD>89</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</TD><TD>MSigDB lists</TD><TD>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</TD><TD>83</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>HOEBEKE_LYMPHOID_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>HOEBEKE_LYMPHOID_STEM_CELL_DN</TD><TD>83</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.228e-02</TD><TD>-3.43</TD><TD>USP15 (ubiquitin specific peptidase 15)</TD><TD>protein interactions</TD><TD>9958</TD><TD>131</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.276e-02</TD><TD>-3.42</TD><TD>female gonad development</TD><TD>biological process</TD><TD>GO:0008585</TD><TD>91</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.303e-02</TD><TD>-3.41</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</TD><TD>MSigDB lists</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.303e-02</TD><TD>-3.41</TD><TD>SEIDEN_ONCOGENESIS_BY_MET</TD><TD>MSigDB lists</TD><TD>SEIDEN_ONCOGENESIS_BY_MET</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.303e-02</TD><TD>-3.41</TD><TD>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</TD><TD>MSigDB lists</TD><TD>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.339e-02</TD><TD>-3.40</TD><TD>central</TD><TD>COSMIC cancer mutations</TD><TD>central</TD><TD>86</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.347e-02</TD><TD>-3.40</TD><TD>maintenance of location in cell</TD><TD>biological process</TD><TD>GO:0051651</TD><TD>93</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>3.357e-02</TD><TD>-3.39</TD><TD>Nucleotide-diphossugar_trans</TD><TD>interpro domains</TD><TD>IPR029044</TD><TD>89</TD><TD>1</TD><TD>18293</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.362e-02</TD><TD>-3.39</TD><TD>skin-extremity-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-extremity-malignant_melanoma</TD><TD>1967</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,FAM198B,MECOM</TD></TR>
<TR><TD>3.366e-02</TD><TD>-3.39</TD><TD>extremity</TD><TD>COSMIC cancer mutations</TD><TD>extremity</TD><TD>1968</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,FAM198B,MECOM</TD></TR>
<TR><TD>3.377e-02</TD><TD>-3.39</TD><TD>voltage-gated potassium channel complex</TD><TD>cellular component</TD><TD>GO:0008076</TD><TD>86</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.380e-02</TD><TD>-3.39</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>MSigDB lists</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>87</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.382e-02</TD><TD>-3.39</TD><TD>myeloid cell homeostasis</TD><TD>biological process</TD><TD>GO:0002262</TD><TD>94</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.398e-02</TD><TD>-3.38</TD><TD>PRMT1 (protein arginine methyltransferase 1)</TD><TD>protein interactions</TD><TD>3276</TD><TD>138</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.416e-02</TD><TD>-3.38</TD><TD>potassium channel complex</TD><TD>cellular component</TD><TD>GO:0034705</TD><TD>87</TD><TD>1</TD><TD>17570</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.418e-02</TD><TD>-3.38</TD><TD>SANA_TNF_SIGNALING_DN</TD><TD>MSigDB lists</TD><TD>SANA_TNF_SIGNALING_DN</TD><TD>88</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>3.423e-02</TD><TD>-3.37</TD><TD>HDAC4 (histone deacetylase 4)</TD><TD>protein interactions</TD><TD>9759</TD><TD>139</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.453e-02</TD><TD>-3.37</TD><TD>development of primary female sexual characteristics</TD><TD>biological process</TD><TD>GO:0046545</TD><TD>96</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.453e-02</TD><TD>-3.37</TD><TD>limbic system development</TD><TD>biological process</TD><TD>GO:0021761</TD><TD>96</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.465e-02</TD><TD>-3.36</TD><TD>Znf_C2H2-like</TD><TD>interpro domains</TD><TD>IPR015880</TD><TD>800</TD><TD>2</TD><TD>18293</TD><TD>7</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>3.533e-02</TD><TD>-3.34</TD><TD>CAATGCA,MIR-33</TD><TD>MSigDB lists</TD><TD>CAATGCA,MIR-33</TD><TD>91</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.544e-02</TD><TD>-3.34</TD><TD>RPL24 (ribosomal protein L24)</TD><TD>protein interactions</TD><TD>6152</TD><TD>144</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.554e-02</TD><TD>-3.34</TD><TD>central nervous system development</TD><TD>biological process</TD><TD>GO:0007417</TD><TD>859</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2,MECOM</TD></TR>
<TR><TD>3.595e-02</TD><TD>-3.33</TD><TD>post-embryonic development</TD><TD>biological process</TD><TD>GO:0009791</TD><TD>100</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.595e-02</TD><TD>-3.33</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>793</TD><TD>2</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,CNTNAP2</TD></TR>
<TR><TD>3.602e-02</TD><TD>-3.32</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.260</TD><TD>73</TD><TD>1</TD><TD>9988</TD><TD>5</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.609e-02</TD><TD>-3.32</TD><TD>MENSE_HYPOXIA_UP</TD><TD>MSigDB lists</TD><TD>MENSE_HYPOXIA_UP</TD><TD>93</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.641e-02</TD><TD>-3.31</TD><TD>SUV39H1 (suppressor of variegation 3-9 homolog 1 (Drosophila))</TD><TD>protein interactions</TD><TD>6839</TD><TD>148</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>CAHOY_OLIGODENDROCUTIC</TD><TD>MSigDB lists</TD><TD>CAHOY_OLIGODENDROCUTIC</TD><TD>94</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.655e-02</TD><TD>-3.31</TD><TD>RNA polymerase II transcription factor binding</TD><TD>molecular function</TD><TD>GO:0001085</TD><TD>102</TD><TD>1</TD><TD>16491</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.666e-02</TD><TD>-3.31</TD><TD>regulation of fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045598</TD><TD>102</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.701e-02</TD><TD>-3.30</TD><TD>multicellular organismal signaling</TD><TD>biological process</TD><TD>GO:0035637</TD><TD>103</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.714e-02</TD><TD>-3.29</TD><TD>CTBP1 (C-terminal binding protein 1)</TD><TD>protein interactions</TD><TD>1487</TD><TD>151</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.724e-02</TD><TD>-3.29</TD><TD>GRADE_COLON_AND_RECTAL_CANCER_DN</TD><TD>MSigDB lists</TD><TD>GRADE_COLON_AND_RECTAL_CANCER_DN</TD><TD>96</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.736e-02</TD><TD>-3.29</TD><TD>cerebral cortex development</TD><TD>biological process</TD><TD>GO:0021987</TD><TD>104</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>3681</TD><TD>4</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,FAM198B,PLOD2,MECOM</TD></TR>
<TR><TD>3.761e-02</TD><TD>-3.28</TD><TD>middle_third</TD><TD>COSMIC cancer mutations</TD><TD>middle_third</TD><TD>3683</TD><TD>4</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,FAM198B,PLOD2,MECOM</TD></TR>
<TR><TD>3.800e-02</TD><TD>-3.27</TD><TD>TAVAZOIE_METASTASIS</TD><TD>MSigDB lists</TD><TD>TAVAZOIE_METASTASIS</TD><TD>98</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>3.807e-02</TD><TD>-3.27</TD><TD>regulation of cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:1903844</TD><TD>106</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.807e-02</TD><TD>-3.27</TD><TD>regulation of transforming growth factor beta receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0017015</TD><TD>106</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.892e-02</TD><TD>-3.25</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</TD><TD>MSigDB lists</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</TD><TD>827</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.948e-02</TD><TD>-3.23</TD><TD>female sex differentiation</TD><TD>biological process</TD><TD>GO:0046660</TD><TD>110</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2</TD></TR>
<TR><TD>3.953e-02</TD><TD>-3.23</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>102</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.953e-02</TD><TD>-3.23</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</TD><TD>MSigDB lists</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</TD><TD>102</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0090101</TD><TD>111</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.990e-02</TD><TD>-3.22</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.550.10</TD><TD>81</TD><TD>1</TD><TD>9988</TD><TD>5</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.991e-02</TD><TD>-3.22</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>MSigDB lists</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>103</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.991e-02</TD><TD>-3.22</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</TD><TD>MSigDB lists</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</TD><TD>103</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.021e-02</TD><TD>-3.21</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.160.60</TD><TD>679</TD><TD>2</TD><TD>9988</TD><TD>5</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>4.077e-02</TD><TD>-3.20</TD><TD>SMAD1 (SMAD family member 1)</TD><TD>protein interactions</TD><TD>4086</TD><TD>166</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.095e-02</TD><TD>-3.20</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>3776</TD><TD>4</TD><TD>17775</TD><TD>7</TD>
<TD>SUN3,CNTNAP2,PLOD2,TOX2</TD></TR>
<TR><TD>4.329e-02</TD><TD>-3.14</TD><TD>myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>112</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.329e-02</TD><TD>-3.14</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>112</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.333e-02</TD><TD>-3.14</TD><TD>MODULE_397</TD><TD>MSigDB lists</TD><TD>MODULE_397</TD><TD>112</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>ZNF432</TD></TR>
<TR><TD>4.357e-02</TD><TD>-3.13</TD><TD>membrane organization</TD><TD>biological process</TD><TD>GO:0061024</TD><TD>959</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3,CNTNAP2</TD></TR>
<TR><TD>4.371e-02</TD><TD>-3.13</TD><TD>LEE_NEURAL_CREST_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>LEE_NEURAL_CREST_STEM_CELL_DN</TD><TD>113</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.371e-02</TD><TD>-3.13</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>MSigDB lists</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>113</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.416e-02</TD><TD>-3.12</TD><TD>chromosome organization</TD><TD>biological process</TD><TD>GO:0051276</TD><TD>966</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>4.446e-02</TD><TD>-3.11</TD><TD>scalp</TD><TD>COSMIC cancer mutations</TD><TD>scalp</TD><TD>2188</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>ZNF432,FAM198B,MECOM</TD></TR>
<TR><TD>4.463e-02</TD><TD>-3.11</TD><TD>KAT2B (K(lysine) acetyltransferase 2B)</TD><TD>protein interactions</TD><TD>8850</TD><TD>182</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.523e-02</TD><TD>-3.10</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</TD><TD>MSigDB lists</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</TD><TD>117</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>embryonic limb morphogenesis</TD><TD>biological process</TD><TD>GO:0030326</TD><TD>127</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>embryonic appendage morphogenesis</TD><TD>biological process</TD><TD>GO:0035113</TD><TD>127</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.549e-02</TD><TD>-3.09</TD><TD>DNA binding</TD><TD>molecular function</TD><TD>GO:0003677</TD><TD>2437</TD><TD>3</TD><TD>16491</TD><TD>6</TD>
<TD>ZNF432,TOX2,MECOM</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.200</TD><TD>93</TD><TD>1</TD><TD>9988</TD><TD>5</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.582e-02</TD><TD>-3.08</TD><TD>cell recognition</TD><TD>biological process</TD><TD>GO:0008037</TD><TD>128</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.582e-02</TD><TD>-3.08</TD><TD>nucleus organization</TD><TD>biological process</TD><TD>GO:0006997</TD><TD>128</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>4.598e-02</TD><TD>-3.08</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>MSigDB lists</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>119</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.632e-02</TD><TD>-3.07</TD><TD>secretory</TD><TD>COSMIC cancer mutations</TD><TD>secretory</TD><TD>120</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.632e-02</TD><TD>-3.07</TD><TD>meninges-meningioma-secretory</TD><TD>COSMIC cancer mutations</TD><TD>meninges-meningioma-secretory</TD><TD>120</TD><TD>1</TD><TD>17775</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.636e-02</TD><TD>-3.07</TD><TD>TOOKER_GEMCITABINE_RESISTANCE_DN</TD><TD>MSigDB lists</TD><TD>TOOKER_GEMCITABINE_RESISTANCE_DN</TD><TD>120</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.652e-02</TD><TD>-3.07</TD><TD>learning</TD><TD>biological process</TD><TD>GO:0007612</TD><TD>130</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.712e-02</TD><TD>-3.06</TD><TD>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</TD><TD>MSigDB lists</TD><TD>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</TD><TD>122</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>FAM198B</TD></TR>
<TR><TD>4.714e-02</TD><TD>-3.05</TD><TD>CTTTAAR_UNKNOWN</TD><TD>MSigDB lists</TD><TD>CTTTAAR_UNKNOWN</TD><TD>918</TD><TD>2</TD><TD>17758</TD><TD>7</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>4.722e-02</TD><TD>-3.05</TD><TD>cell maturation</TD><TD>biological process</TD><TD>GO:0048469</TD><TD>132</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.722e-02</TD><TD>-3.05</TD><TD>negative regulation of cellular response to growth factor stimulus</TD><TD>biological process</TD><TD>GO:0090288</TD><TD>132</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.732e-02</TD><TD>-3.05</TD><TD>response to hormone</TD><TD>biological process</TD><TD>GO:0009725</TD><TD>1003</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>PLOD2,TOX2</TD></TR>
<TR><TD>4.784e-02</TD><TD>-3.04</TD><TD>positive regulation of transcription from RNA polymerase II promoter</TD><TD>biological process</TD><TD>GO:0045944</TD><TD>1009</TD><TD>2</TD><TD>16441</TD><TD>6</TD>
<TD>TOX2,MECOM</TD></TR>
<TR><TD>4.792e-02</TD><TD>-3.04</TD><TD>mitophagy in response to mitochondrial depolarization</TD><TD>biological process</TD><TD>GO:0098779</TD><TD>134</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.792e-02</TD><TD>-3.04</TD><TD>response to mitochondrial depolarisation</TD><TD>biological process</TD><TD>GO:0098780</TD><TD>134</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.825e-02</TD><TD>-3.03</TD><TD>IQCB1 (IQ motif containing B1)</TD><TD>protein interactions</TD><TD>9657</TD><TD>197</TD><TD>1</TD><TD>16036</TD><TD>4</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.825e-02</TD><TD>-3.03</TD><TD>CCTGTGA,MIR-513</TD><TD>MSigDB lists</TD><TD>CCTGTGA,MIR-513</TD><TD>125</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.828e-02</TD><TD>-3.03</TD><TD>ZINC_FINGER_C2H2_2</TD><TD>prosite domains</TD><TD>PS50157</TD><TD>732</TD><TD>2</TD><TD>11866</TD><TD>6</TD>
<TD>ZNF432,MECOM</TD></TR>
<TR><TD>4.862e-02</TD><TD>-3.02</TD><TD>maintenance of location</TD><TD>biological process</TD><TD>GO:0051235</TD><TD>136</TD><TD>1</TD><TD>16441</TD><TD>6</TD>
<TD>SUN3</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>angiosarcoma</TD><TD>2284</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2,MECOM</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>2284</TD><TD>3</TD><TD>17775</TD><TD>7</TD>
<TD>CNTNAP2,TOX2,MECOM</TD></TR>
<TR><TD>4.976e-02</TD><TD>-3.00</TD><TD>RELA_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>RELA_DN.V1_DN</TD><TD>129</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.976e-02</TD><TD>-3.00</TD><TD>KEGG_CELL_ADHESION_MOLECULES_CAMS</TD><TD>MSigDB lists</TD><TD>KEGG_CELL_ADHESION_MOLECULES_CAMS</TD><TD>129</TD><TD>1</TD><TD>17758</TD><TD>7</TD>
<TD>CNTNAP2</TD></TR>
</TABLE>
</BODY></HTML>
